Open AccessGenes, proteins and complexes: the multifaceted nature of FHL family proteins in diverse tissues
Author(s) -
Shathasivam Thiruchelvi,
Kislinger Thomas,
Gramolini Anthony O.
Publication year - 2010
Publication title -
journal of cellular and molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.44
H-Index - 130
eISSN - 1582-4934
pISSN - 1582-1838
DOI - 10.1111/j.1582-4934.2010.01176.x
Subject(s) - lim domain , biology , phenotype , ectopic expression , skeletal muscle , actin , genetics , gene , microbiology and biotechnology , myopathy , protein domain , computational biology , transcription factor , anatomy , zinc finger
Abstract• Overview• FHL1: structure, organization, and function‐ The LIM domain‐ Spliced variants of FHL1‐ Notch signalling and KYOT2/3 proteins‐ Expression patterns of FHL1• FHL1 and disease‐ FHL1 and skeletal muscle myopathies‐ FHL1 expression levels in cardiovascular diseases‐ FHL1 and muscle‐associated functions‐ FHL1 and its transcriptional regulation functions in cancer• PerspectivesFour and a half LIM domain protein 1 (FHL1) is the founding member of the FHL family of proteins characterized by the presence of four and a half highly conserved LIM domains. The LIM domain is a protein‐interaction motif and is involved in linking proteins with both the actin cytoskeleton and transcriptional machinery. To date, more than 25 different protein interactions have been identified for full length FHL1 and its spliced variants, and these interactions can be mapped to a variety of functional classes. Because FHL1 is expressed predominantly in skeletal muscle, all of these proteins interactions translate into a multifunctional and integral role for FHL1 in muscle development, structural maintenance, and signalling. Importantly, 27 FHL1 genetic mutations have been identified that result in at least six different X‐linked myopathies, with patients often presenting with cardiovascular disease. FHL1 expression is also significantly up‐regulated in a variety of cardiac disorders, even at the earliest stages of disease onset. Alternatively, FHL1 expression is suppressed in a variety of cancers, and ectopic FHL1 expression offers potential for some phenotype rescue. This review focuses on recent studies of FHL1 in muscular dystrophies and cardiovascular disease, and provides a comprehensive review of FHL1s multifunctional roles in skeletal muscle.